Cargando…
Recombinant Viral Vaccines Expressing Merozoite Surface Protein-1 Induce Antibody- and T Cell-Mediated Multistage Protection against Malaria
Protecting against both liver and blood stages of infection is a long-sought goal of malaria vaccine design. Recently, we described the use of replication-defective viral vaccine vectors expressing the malaria antigen merozoite surface protein-1 (MSP-1) as an antimalarial vaccine strategy that elici...
Autores principales: | Draper, Simon J., Goodman, Anna L., Biswas, Sumi, Forbes, Emily K., Moore, Anne C., Gilbert, Sarah C., Hill, Adrian V.S. |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Cell Press
2009
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2663714/ https://www.ncbi.nlm.nih.gov/pubmed/19154991 http://dx.doi.org/10.1016/j.chom.2008.12.004 |
Ejemplares similares
-
Recombinant Viral Vaccines Expressing Merozoite Surface Protein-1 Induce Antibody- and T Cell-Mediated Multistage Protection against Malaria
por: Draper, Simon J., et al.
Publicado: (2011) -
The utility of Plasmodium berghei as a rodent model for anti-merozoite malaria vaccine assessment
por: Goodman, Anna L., et al.
Publicado: (2013) -
Towards a multi-antigen multi-stage malaria vaccine
por: Hill, Adrian VS, et al.
Publicado: (2014) -
Progress with viral vectored malaria vaccines: A multi-stage approach involving “unnatural immunity”
por: Ewer, Katie J., et al.
Publicado: (2015) -
A Viral Vectored Prime-Boost Immunization Regime Targeting the Malaria Pfs25 Antigen Induces Transmission-Blocking Activity
por: Goodman, Anna L., et al.
Publicado: (2011)